Regulation of scleral cell contraction by transforming growth factor-β and stress competing roles in myopic growth by Jobling, Andrew I. et al.
	 	
	
 
 
This is the published version:  
 
Jobling,	Andrew	I.,	Gentle,	Alex,	Metlapally,	Ravikanth,	McGowan,	Bryan	J.	and	McBrien,	Neville	A.	
2008,	Regulation	of	scleral	cell	contraction	by	transforming	growth	factor‐β	and	stress	competing	
roles	in	myopic	growth,	Journal	of	biological	chemistry,	vol.	284,	pp.	2072‐2079.	
	
	
Available from Deakin Research Online: 
 
http://hdl.handle.net/10536/DRO/DU:30064473	
	
	
	
Reproduced	with	the	kind	permission	of	the	copyright	owner	
	
	
Copyright	:	2008,	PubMed	Central	
Regulation of Scleral Cell Contraction by Transforming
Growth Factor- and Stress
COMPETING ROLES INMYOPIC EYE GROWTH*
Received for publication, September 29, 2008, and in revised form,November 13, 2008 Published, JBC Papers in Press,November 14, 2008,DOI 10.1074/jbc.M807521200
Andrew I. Jobling, Alex Gentle, Ravikanth Metlapally, Bryan J. McGowan, and Neville A. McBrien1
From the Department of Optometry and Vision Sciences, The University of Melbourne, Victoria 3010, Australia
Reduced extracellular matrix accumulation in the sclera of
myopic eyes leads to increased ocular extensibility and is related
to reduced levels of scleral transforming growth factor- (TGF-
). The current study investigated the impact of this extracellu-
lar environment on scleral cell phenotype and cellular biome-
chanical characteristics. Scleral cell phenotype was investigated
in vivo in a mammalian model of myopia using the myofibro-
blast marker,-smoothmuscle actin (-SMA). In eyes develop-
ing myopia -SMA levels were increased, suggesting increased
numbers of contractile myofibroblasts, and decreased in eyes
recovering from myopia. To understand the factors regulating
this change in scleral phenotype, the competing roles of TGF-
andmechanical stress were investigated in scleral cells cultured
in three-dimensional collagen gels. All three mammalian iso-
forms of TGF- altered scleral cell phenotype to produce highly
contractile, -SMA-expressing myofibroblasts (TGF-3 >
TGF-2 > TGF-1). Exposure of cells to the reduced levels of
TGF- found in the sclera in myopia produced decreased cell-
mediated contraction and reduced -SMA expression. These
findings are contrary to the in vivo gene expression data. How-
ever, when cells were exposed to both the increased stress and
the reduced levels of TGF- found inmyopia, increased-SMA
expression was observed, replicating in vivo findings. These
results show that although reduced scleral TGF- is a major
contributor to the extracellular matrix remodeling in the
myopic eye, it is the resulting increase in scleral stress that dom-
inates the competing TGF- effect, inducing increased -SMA
expression and, hence, producing a larger population of con-
tractile cells in the myopic eye.
Myopia is a highly prevalent ocular condition, the major
symptom of which is blurred distance vision. The primary
structural cause of myopia is increased axial length of the eye,
and a significant number of myopes (15% of myopes or 3% of
the general population) have high degrees ofmyopia and exces-
sively long eyes (25.5 mm). The outer coat of the eye, the
sclera, becomes pathologically thin in highly myopic eyes, the
resultant biomechanical instability in turn resulting in damage
to the retina and choroid, causing irreversible loss of vision (1).
The mammalian sclera is a typical fibrous connective tissue,
predominantly constructed of heterotypic collagen fibrils rich
in type I collagen (2, 3). Scleral biomechanical changes in path-
ological myopia are well documented both in humans and in
animal models, with the sclera of myopic eyes demonstrating
increased extensibility with increasing levels of myopia (4, 5). It
is now widely accepted that although the thinner sclera in high
myopia contributes to increased extensibility, changes in the
biochemical structure of the sclera make an independent con-
tribution to this increased extensibility. Themajor biochemical
contributors to altered scleral biomechanics are reduced scleral
collagen content, thinner collagen fibrils, and reduced amounts
of sulfated and non-sulfated scleral glycosaminoglycans (6–9).
The overall effect of these changes is a weakened collagen
matrix with increased internal stresses.
There is substantive evidence of the contribution of extracel-
lular matrix (ECM)2 factors to increased scleral extensibility in
myopia. However, data from other connective tissue systems
highlight the contribution of contractile cellular elements to
tissue biomechanics (10), suggesting that factors other than the
ECM might contribute to scleral biomechanical properties.
Indeed two findings demonstrate that scleral mechanical prop-
erties may partly be a function of scleral cell physiology. First,
rapid (1 h) shortening of eye length has been shown to coun-
teract high intraocular pressures, a time frame that is not easily
explainable by matrix remodeling. Second, scleral cells were
shown to express -smooth muscle actin (-SMA), a cytoskel-
etal protein characteristic of contractile myofibroblasts (11).
Myofibroblasts are cells that express a variety of cytoskeletal
proteins, most importantly -SMA, that afford the cell con-
tractile properties (12). This contractile capability makes myo-
fibroblasts important in ECM repair and wound contraction
(13). There is debate regarding the origin ofmyofibroblast cells;
however, it seems that these cells may arise from a variety of
sources, either directly from embryonic mesenchyme through
differentiation from fibroblasts or through differentiation from
other cell types such as epithelium (14). The proportion ofmyo-
fibroblasts within the sclera and their permanence remains to
be demonstrated; however, it has been suggested that their
numbers increase with age, and it is assumed that they differ-
entiate from scleral fibroblasts (15). If a permanent population
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of myofibroblasts exists in the sclera, this would be a rarity in
the body and probably occurs because the intraocular pressure
puts the scleralmatrix under constant tension, one factor that is
known to promote myofibroblast differentiation. The process
of differentiation of myofibroblasts has been relatively well
characterized in other tissue systems, and along with biome-
chanical stresses, the growth factor transforming growth fac-
tor- (TGF-) has been shown to play a major role (14).
TGF- is of primary importance in the regulation of ECM
turnover, and the three mammalian isoforms of TGF- have
been shown to regulate collagen production by scleral cells.
Furthermore, TGF- isoform changes, which occur within 24 h
of the initiation ofmyopia development, have been linked to the
altered regulation of ECM production found in the sclera of
eyes developing myopia (16).
The current study sought to investigate the link between
scleral TGF- levels, the changing scleral extracellular matrix,
and the presence and function of myofibroblasts in the sclera
duringmyopic eye growth. The study had three specific aims: 1)
to characterize the expression of -SMA in eyes developing
myopia and in eyes starting to recover from induced myopia,
thus elucidating changes in the scleral myofibroblast popula-
tion during altered eye growth; 2) to investigate the capacity of
TGF- to control scleral cell phenotype and contractile prop-
erties and determine the cellular capacity to contribute to the
overall biomechanical characteristics of the sclera; 3) to inves-
tigate the competing influences of TGF- and stress on scleral
myofibroblast differentiation and biomechanical properties,
thus determining the mechanism(s) of phenotypic change in
scleral cells during myopic eye growth.
EXPERIMENTAL PROCEDURES
Experimental Animals—In all experimental studies, tree
shrew (Tupaia belangeri) pups were used, with treatment
beginning 15 days after natural eye opening. This period is opti-
mal for inducing changes in eye size (17). This mammalian ani-
mal model is well established in eye growth studies and has
similar ocular anatomy to human (18). In animals where exper-
imental myopia was induced, they underwent a small surgical
procedure to attach a head-mounted goggle, enabling a trans-
lucent occluder to be placed over one eye (19). The unoccluded
eye (contralateral control eye) served as a within-animal con-
trol for gene expression studies. Right and left eyes were ran-
domized as treated and contralateral control eyes throughout
the study.Myopia was induced for 24 h (n 5) or 5 days (n 5)
during which time the animals were exposed to a 14/10 light/
dark cycle, and food and water were available ad libitum. In a
separate group of animals (n  5) myopia was induced for 5
days, after which the occluder was removed, and unoccluded
vision was restored for 24 h (recovery group). A group of visu-
ally un-manipulated animals (n 5) was also included to pro-
vide normative base-line data. Animals used for cell culture
studies were age-matched to the 5-day treatment group (i.e.
scleral cells were isolated 20 days post-eye opening). All of the
procedures were carried out in accordance with the National
Health andMedical Research Council of Australia’s Guidelines
for the Care and Use of Animals in Research.
Materials—Dulbecco’s modified Eagle’s medium and trypsin
were obtained from Invitrogen; fetal bovine serum was
obtained from JRH (Melbourne, Australia); cell culture vessels
were obtained from Nunc (Roskilde, Denmark) and Flexcell
International Corp. (Hillsborough NC); recombinant human
TGF- proteins were obtained from Chemicon International
(Temecula, CA); collagen type Imatrixwas purchased fromMP
Biomedicals (Cellagen; Aurora, OH); PCR primers were
obtained from Sigma-Proligo; guanidine thiocyanate, DNase I,
Moloney murine leukemia virus reverse transcriptase, dNTPs,
and RNasin were obtained from Promega (Madison,WI); Fast-
Start DNA Master Mix was obtained from Roche Applied Sci-
ence; RNeasy mini extraction and QIAquick PCR purification
kits were obtained fromQiagen (Valencia, CA); protein estima-
tion kits were purchased from Bio-Rad (Dc Protein); fluores-
cent goat anti-mouse and goat anti-rabbit antibodies were
obtained from Molecular Probes (Eugene, OR); horseradish
peroxidase-conjugated antibody, film, and the ECL detection
kit were obtained from GE Healthcare; vimentin antibody
(H-84) was obtained from Santa Cruz Biotechnology (Santa
Cruz, CA), whereas the -SMA monoclonal antibody clone
1A4, 4,6-diamidino-2-phenylindole, and all other reagents
were purchased from Sigma-Aldrich.
Tissue Collection—After the designated treatment periods,
animals were terminally anesthetized (90 mg/kg ketamine and
10 mg/kg xylazine followed by 120 mg/kg sodium pentobarbi-
tal), and the eyes were enucleated. The left eye was always
removed first in those animals that hadmyopia induced to ran-
domize the processing of the treated and contralateral control
eye tissue. The isolation of scleral tissue was performed as pre-
viously described (20). For gene expression studies, a 7-mm
surgical trephine was used to isolate the posterior sclera, which
was immediately placed in liquid nitrogen and subsequently
stored at 80 °C until use. For Western blot and cell culture
studies, whole sclera was isolated and processed as detailed
below.
Primary Cell Culture—Primary tree shrew scleral fibroblast
cells were established and maintained (Dulbecco’s modified
Eagle’s medium supplemented with 25 mM HEPES, 100
units/ml penicillin/streptomycin solution, and 10% fetal calf
serum) in culture as previously described (16). Only cells
from passage numbers 2–6 were used, as previous unpub-
lished work had shown these cells to exhibit stable growth
curves and morphology.
To characterize scleral fibroblast differentiation, scleral
fibroblasts were seeded (5  104 cells) into 24-well plates and
grown until confluent. Cells were subsequently washed and
placed in low serum media (growth medium containing 1%
serum) for 24 h. The medium was then replaced and supple-
mented with a combination of TGF- isoforms (ratio, 2 1:33
2:1 3) at a final concentration of 0.55 ng/ml. This combina-
tion matches the observed in vivo TGF- isoform levels, as
described in a previous publication (16). Cells were incubated
for a further 48 h and then isolated for gene expression studies.
Collagen Gel Contraction—Scleral cells were seeded in a
three-dimensional collagen type I matrix to achieve a final col-
lagen concentration of 2.1 mg/ml, with cell densities ranging
from 1  105 to 5  105 cells/cm3. The cell-populated matrix
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was added to 24well plates and polymerized at 37 °C for 15min,
and 1 ml of growth media was overlaid. In a subset of experi-
ments, collagen matrices containing 5  105 cells/cm3 were
exposed to growth medium containing TGF- combinations
that modeled those found in normal and myopic eye sclerae.
Thematrices remained attached to the culture vessel walls for 5
days to increase stresses. After this time, the matrix was
released from the culture vessel, and the reduction in matrix
surface area was quantified over 96 h using a high resolution
scanner.
Stress Manipulation in Collagen Gels—Matrix stress was
manipulated in vitro using the TissueTrain cell culture system
(Flexcell Int. Corp.). Using the specialized culture plates, scleral
cells (2 105) were seeded into a collagen type Imatrix (200l)
and polymerized, and 3 ml of growth media were added. After
48 h, the three-dimensional matrices were washed and placed
in low serummedia (1% serum) for 24 h. Themediumwas then
replaced and supplemented with a combination of TGF- iso-
forms (ratio, 2 1:33 2:1 3) modeling those found in normal
and myopic eye sclerae. The matrices were then exposed to
either no stress or a static stress (8.5% elongation) for 5 days.
The calculated level of static stress was based on normal
intraocular pressure (15mmHg) and was scaled for volumetric
differences between the sclera and three-dimensional gel. After
5 days, the matrices were collected, and total cellular RNA was
extracted.
Total RNA Isolation and Reverse Transcription—For gene
expression and stress manipulation studies, total RNA was iso-
lated using phenol chloroform extraction (21), whereas com-
mercial silica columns were used for isolation from cultured
cells. During extraction, total RNAwas treated with DNase I to
remove residual genomic contamination, then re-purified and
quantified spectrophotometrically. Reverse transcription was
carried out using 0.5g of total RNA, randomhexamer primers
(12.5 ng/ml), andMoloneymurine leukemia virus reverse tran-
scriptase, as permanufacturer’s instructions. cDNAwas diluted
to5 ng/ml and stored at20 °C until use.
Quantitative Real-time PCR—Changes in -SMA and
TGF- isoform gene expression were quantified using the
LightCycler real time PCR machine (Roche Diagnostics) and
SYBR Green. mRNA copy numbers were calculated relative to
external standards and the housekeeping transcripts hypoxan-
thine phosphoribosyltransferase and ribosomal 18 S. The exter-
nal standards were produced using tree shrew-specific primers,
and the products were purified and quantified at 260 nm. A
serially diluted four-point standard curve was included in every
amplification protocol, and all samples were amplified in trip-
licate (Table 1, TGF- amplification conditions as per the pre-
vious publication (16)). Amplification curves were analyzed
using the fit points method (Roche Diagnostics), and group
mean datawere expressed as the percentage difference between
treated eye and contralateral control eye (S.E.). Differences in
gene expression were assessed with paired t tests.
Immunocytochemistry—Tree shrew scleral fibroblasts were
grown on collagen type I-coated slides, exposed to the TGF-
combination (as above) for 5 days, and then fixed in 4%
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Cell
monolayers were treated with the -SMA and vimentin anti-
bodies (as permanufacturer’s protocol) and subsequently incu-
bated with a fluorophore-conjugated secondary antibody (goat
anti-mouse, Alexa Fluor 488 and goat anti-rabbit, Alexa Fluor
594, respectively). Cell nuclei were stained with 4,6-dia-
midino-2-phenylindole, and the specific stainingwas visualized
on an Axiophot II microscope (Carl Zeiss). Negative controls
(minus -SMA and vimentin antibodies) were performed in
parallel.
SDS-PAGE andWestern Blot—Sclerae from 24-h treated and
contralateral control eyes, and scleral cells treatedwith or with-
out TGF- combinations were isolated and homogenized in a
tissue lysis buffer (20mMTris-HCl, 150mMNaCl, 10% glycerol,
1% Triton X-100 (pH 7.2)). Insoluble material was removed
after centrifugation (10min at 13 000 g). Protein content was
estimated, identical amounts (40 g) were loaded onto a dena-
turing 12.5% acrylamide gel, and the constituents were sepa-
rated using SDS-PAGE. The method of Towbin and Gordon
(22) was used for Western blotting. The -SMA antibody was
used at a concentration of 1 g/ml, and the horseradish perox-
idase-conjugated secondary antibodywas used at a dilution of 1
in 2500 from the manufacturer’s stock solution. Bands repre-
senting -SMA were visualized through chemiluminescence.
RESULTS
Scleral -SMA Expression in Eyes Developing and Recovering
fromMyopia—Myopiawas inducedmonocularly in tree shrews
for 24 h, at which point no changes in eye size were apparent,
and 5 days, by which time animals developed high levels of
myopia. A subset of the 5-day myopic animals had the myopia-
inducing occluder removed and were allowed to start recover-
ing from induced myopia for 24 h, a process that involved a
reversal of the axial elongation of the eye.
Western blot analysis confirmed the presence of-SMApro-
tein (myofibroblast marker) in the sclera. Scleral samples from
the treated and control eyes of an animal that had had myopia
induced for 24 h generated bands at 43 kDa, the expected size
TABLE 1
Oligonucleotide primers and quantitative real-time PCR conditions
Tree shrew-specific primers are shown 5 to 3. Genes were amplified via PCR using a 40-cycle amplification protocol. Amplification of the housekeeping genes was
optimized using touchdown protocols (annealing temperature decreasing at 1 °C per cycle). The gene-specific amplification conditions, including the fluorescent signal
acquisition temperature, are detailed. HPRT, hypoxanthine phosphoribosyltransferase.
Gene Primer sequence PCR conditionsForward Reverse 	MgCl2
 Ann. temp Ext. time Signal temp
°C s °C
-SMA ccgaccgaatgcagaagga cagagctttggctaggaatga 3 mM 60 12 87
HPRT ggaggccatcacatcgtagc cgacaatcaagacattctttcc 4 mM 723 55 12 80
18 S tcgaagacgatcagataccg cgctccaccaactaagaacg 3 mM 723 60 15 85
Scleral Cell Phenotype Regulation andMyopic Eye Growth
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for -SMA, with greater band density in the eye developing
myopia (Fig. 1A). The gene expression data confirmed an up-
regulated in -SMA expression in eyes developing myopia;
however, this was not significant, and there was substantial
inter-animal variability (24 h, 242  172%, p  0.23; 5 days,
58  74%, p  0.48; Fig. 1B). In eyes recovering from the
induced myopia, there was a rapid and significant decrease in
-SMA expression (58  5%, p  0.0005; Fig. 1B). All gene
expression data were re-analyzed with reference to a second
housekeeping gene (18 S; data not shown), and the results were
consistent with the data in Fig. 1B, with no significant differ-
ence between the results normalized to either of the two house-
keeping genes.
Contractile Capabilities of Scleral Cells—To examine the
intrinsicmechanical properties of scleral cells, primary cultures
of scleral fibroblasts were seeded into attached three-dimen-
sional collagen gels, and the contraction parameters were
measured upon release. The composition of the gel was formu-
lated to approximate the in vivo scleral matrix, which is princi-
pally (89%) collagen type 1 (2, 3). Increasing scleral cell den-
sity (1 105 cells/cm3 to 5 105 cells/cm3) resulted in both an
increased initial rate of contraction and a greater maximum
contraction after 4 days (two-way analysis of variance F 8.82;
p 0.0001 for both cell density and time; Bonferroni post-tests
showed that 5 105 cells was significantly different (p 0.05 or
greater) from 1  105 cells at every time point except 0 h; see
Fig. 2). The initial exponential increase in matrix contraction
(24 h) exhibited the greatest density-dependent effect,
whereas the latter rate of contraction (24 h) was relatively
consistent across the different cell densities. Although there
was a progressive decrease in the rapid contractile phase with
reducing cell density, the lowest density (1  105 cells/cm3)
showed no rapid contraction but exhibited a 24-h lag period
before any reduction in matrix area could be quantified. This
lag period has been previously reported in three-dimensional
gel contraction experiments and likely represents the time
taken for generation of tractional force and matrix reorganiza-
tion, among other factors (23, 24).
TGF- Influence on Scleral Cell Contraction and -SMA
Expression—Numerous modulators of cell-mediated matrix
contraction have been identified in other tissue systems, with
TGF- a consistent key regulator. This growth factor is present
within the sclera and has been shown to have an important role
in ECM remodeling during myopia development (16). The
capacity of TGF- to influence the scleral cell contractile prop-
erties was determined by adding a physiologically relevant
TGF- isoform combination (see “Experimental Procedures”)
to a three-dimensional collagen gel containing 1  105 cells/
cm3 scleral fibroblasts. This cell density was chosen because it
resulted in only limited matrix contraction under normal con-
ditions (Fig. 2). The addition of TGF- greatly increased the
initial rate of contraction (650%) and maximal contraction
(700%) achieved by scleral cells relative to the limited con-
traction observed in the no TGF- control (two-way analysis of
variance F  6.2, p  0.0001 for TGF- and time; Bonferroni
post-tests showed that the difference between no TGF- and
TGF-was significant at the p 0.001 level from the 24-h time
point onwards; see Fig. 3).
FIGURE 1. Regulation of -SMA gene expression during development of
and recovery from myopia. A, posterior sclera from the treated and con-
tralateral control eye of animals after 1 day ofmyopia inductionwere homog-
enized, and -SMA protein expression was investigated through Western
blots. 40 g of total protein was loaded, and the protein expression was
assessed using an -SMAmonoclonal antibody (clone 1A4). Size markers are
shown. B, -SMAmRNA gene expression was quantified after 1 and 5 days of
myopia development and 1 day of recovery from inducedmyopia using real-
timequantitative PCR (alln5). Anage-matchednormal groupwas included
as a negative control (n 5). Data are expressed as percentage difference in
expression between the treated and control eyes. For the difference in the
normal data, the left and right eyes were randomized. ***, p 0.0005.
FIGURE 2. Contractile properties of tree shrew scleral fibroblasts. Fibro-
blasts were cultured from scleral explants and seeded into attached collagen
type I matrices at varying densities (1–5  105 cells/cm3). After 5 days the
matrix was released, and the reduction in surface area quantified and con-
verted to % contraction of the matrix. Two-way analysis of variance F 8.82,
p  0.0001 for cell number and p  0.0001 for time. Bonferroni post-tests
showed that 5105 cellswas significantly different (p0.05or greater) from
1 105 cells at every time point except 0 h.
Scleral Cell Phenotype Regulation andMyopic Eye Growth
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The mechanism whereby TGF- promoted this increase in
contraction was investigated through the immunocytochemi-
cal identification of -SMA (myofibroblast marker). Cells were
co-labeledwith vimentin, amore general cytoskeletalmarker of
fibroblasts and myofibroblasts. Although extensive vimentin
(red) staining was observed in scleral cells that had not been
exposed to TGF-, limited -SMA staining (green) was appar-
ent (Fig. 4A). -SMA was greatly increased in cells that had
been exposed to the TGF- isoform combination, indicative of
fibroblast tomyofibroblast differentiation (Fig. 4,B andD). The
-SMAand vimentin stainingwas frequently found in the same
cytoskeleton, with both being predominantly arranged in linear
patterns throughout the cytoplasm of the cell, consistent with
labeling of stress fibers within these cells (Fig. 4B). The number
of nuclei (4,6-diamidino-2-phenylindole; blue) remained rela-
tively constant in all sections, suggesting that TGF- had not
greatly increased cell numbers. The negative control for the
TGF--treated cells is also shown (Fig. 4C).
The relative contribution of the three mammalian TGF-
isoforms to the scleral myofibroblast differentiation process
was determined by measuring isoform-specific expression of
scleral -SMA mRNA. A dose-dependent increase in -SMA
expression was observed for all TGF- isoforms, with the peak
inducible expression for the1 and3 isoforms similar (1372%,
1340%, respectively), whereas TGF-2 elicited the smallest
peak increase (770%; Fig. 5). By calculating the EC50 values from
the mean dose-response curves, TGF-3 was found to be the
most potent inducer of -SMA expression in vitro followed by
TGF-2 and TGF-1. This difference in isoform potency was
only significant between TGF-1 and TGF-3 (0.40 versus 1.29
ng/ml p 0.05).
Modeled Effect of TGF- Regulation of -SMA Expression in
Myopia—Changes in scleral TGF- regulation have previously
been reported during myopia development (16). Although
myopia-related changes have been demonstrated after 24 h and
5 days of myopia, TGF- expression in the recovering eye was
unknown. To provide a comprehensive profile of TGF-
changes, isoform gene expression was assessed during recovery
frommyopia. Data showed a significant decrease in expression
of all TGF- isoforms (TGF-1,38 8%, p 0.005; TGF-2,
39  9% p  0.01; TGF-3, 40  10% p  0.01; Fig. 6).
These decreases are similar to those found after 5 days of myo-
pia (16).
To determine whether these alterations would explain the in
vivo regulation of -SMA during myopia, scleral cells were
exposed to either 1) physiological scleral levels of TGF-, 2) the
scleral TGF- levels found during the initial stages (24 h) of
myopia development, or 3) the scleral levels of TGF- found
when structural changes are well established (5 days of myopia
development). Models representing eyes developing myopia
showed reduced contraction at 24 h after gel release in the
condition modeling 24 h of myopia development (19%)
and, furthermore, significant reduction in the condition rep-
resenting eyes with established myopia (36%, p 0.05; Fig.
7). Contrary to expectations from in vivo findings, scleral
cells also showed a significant decrease in expression of
-SMA mRNA under both experimental conditions (29%,
p 0.01 and48%, p 0.005; Fig. 7) with decreases similar
to those observed for matrix contraction.
Influence of Physiological Stress on Modeled Effect of TGF-
Regulation on -SMA Expression in Myopia—In addition to
TGF-, myofibroblast differentiation is also modulated by
imposed ECM stress (14). To reconcile in vivo findings with the
in vitromodel of contractile cell behavior in myopia, the exper-
FIGURE 3. TGF- regulation of scleral fibroblast contraction. Collagen
matrices containing low cell densities (1  105 cells/cm3) were incubated
either with or without TGF- isoform combinations (final 0.55 ng/ml) calcu-
lated from in vivo TGF- concentrations (isoform ratio, 2 1:33 2:1 3; (16)).
After 5 days the matrix was released, and the reduction in surface area was
quantified and converted to% contraction. Two-way analysis of variance F
6.2, p  0.0001 for TGF- and p  0.0001 for time. Bonferroni post-tests
showed that the difference between no TGF- and TGF- was significant at
p 0.001 from the 24-h time point onward.
FIGURE 4. TGF- regulation of scleral fibroblast differentiation. Scleral
fibroblasts were seeded onto collagen type I-coated slides and incubated
with (B) or without (A) the TGF- isoform combination (2 1:33 2:1 3; final
0.55 ng/ml; (16)) for 5 days. The expression of the myofibroblast-marker,
-SMA (green), and vimentin (red) was assessed using fluorescent immunocy-
tochemistry (400), and bars represent 50m. Cell nuclei were stained using
4,6-diamidino-2-phenylindole, and the negative control for the TGF- treat-
ment is shown (C). D, cultured scleral cells either treated with TGF- or with-
out added TGF-were homogenized and -SMA protein expression investi-
gated through Western blots. 40 g of total protein was loaded, and the
proteinexpressionwasassessedusingan-SMAmonoclonal antibody (clone
1A4). Size markers are shown.
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iments described above were replicated in attached three-di-
mensional collagen gels which were exposed to either no stress
or to stresses approximating those in the normal scleral envi-
ronment. As expected from the previous experiments, the addi-
tion of scleral TGF- levels consistent with 24 h and 5 days of
myopia development produced a decrease in -SMA expres-
sion (25  13%, p  0.21 and 31  7%, p  0.05, respec-
tively) when thematrixwas under no stress (Fig. 8). However, in
gels that were exposed to physiological levels of scleral stress,
the addition of the reduced levels of TGF- resulted in a relative
increase in -SMA expression (3215  1992 and 1943% 
1519% respectively; Fig. 8). The stress-induced reversal in the
regulation of -SMA expression, in addition to the high varia-
bility, is consistent with in vivo findings for 24 h and 5 days of
myopia development.
DISCUSSION
This studywas undertaken to characterize scleral cell pheno-
type and properties during myopia development. The data
show that the sclera contains an endogenous population of
myofibroblasts, which are regulated during changes in eye
growth. To explain this regulation, the in vitro biomechanical
properties of these cells were investigated when exposed to
growth factor and stress changes which reflect the scleral
remodeling that occurs during myopia development. The
scleral cells exhibit an intrinsic contractile property that can be
specifically regulated by TGF-. However, the stresses experi-
enced by scleral cells in vivo can override the effect of TGF- on
cell phenotype, suggesting that the increased scleral -SMA
expression during myopia is a response to the increased stress
placed on the cells due to the weakened tissue.
In vivo findings of the current study are in agreement with
those of previous studies (11, 15) in suggesting that the scleral
environment supports a constant population ofmyofibroblasts.
This, however, is the first report detailing the contractile capa-
FIGURE 5. TGF- isoform regulation of scleral -SMA gene expression.
Tree shrew scleral fibroblasts were exposed to increasing concentrations
(0.01–20 ng/ml) of TGF- isoforms for 48 h (TGF-1 (A), TGF-2 (B), TGF-3 (C)
each n  3). -SMA gene expression was assessed relative to a no TGF-
control using real-time PCR. Curves were fitted, and EC50 values determined
using a three-parameter logistic equation.
FIGURE 6. Regulation of TGF- isoform expression during recovery from
myopia. TGF- isoform gene expression was quantified after 1 day of recov-
ery from induced myopia using real-time quantitative PCR (n 5). Data are
expressed as percentage difference in expression between the treated and
control eyes. **, p 0.01; ***, p 0.005.
FIGURE 7. The effect of myopia-induced TGF- changes on scleral cell
contraction and -SMA expression. Scleral fibroblasts were exposed to
TGF- combinations thatwere calculated fromthe in vivodecreasesobserved
during1and5daysofmyopia induction (16). Fibroblast-seededmatrices (1
105 cells/cm3) were exposed to the different levels of TGF- (normal, 1 day
myopia, 5daysmyopia) for 5days and, upon release, the%matrix contraction
was calculated. The effect of the myopia-induced decreases in TGF- on
-SMA gene expression was assessed after 48 h using real-time PCR. Gene
expression data were relative to hypoxanthine phosphoribosyltransferase,
and all data were compared with the TGF- levels found in normal eyes. n
3; *, p 0.05; **, p 0.01; ***, p 0.005.
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bilities of scleral cells. The finding of a relatively consistent pop-
ulation of myofibroblasts is uncommon elsewhere in the body
andmakes the sclera a potentially important model in which to
investigate the role of myofibroblasts in normal tissue homeo-
stasis and aging. Consistent with reports in other tissue sys-
tems, the current study has demonstrated that scleral fibroblast
cells adopt a density-dependent contractile phenotype when
maintained in stressed (attached) matrices. The contraction
curves in attached gels exhibited a biphasic response, with an
initial (24 h) rapid contraction of the matrix followed by a
slower linear reduction in matrix area (see Fig. 2). The density-
dependent nature of the initial period of stress relaxation
reflects the cell-mediated traction built up in the attached
matrix (25, 26), whereas the density-independent contraction
(24 h) likely represents the capacity of scleral cells to contract
their surrounding ECM under little or no stress. This is sup-
ported by previous work that showed that during the initial
relaxation period cells retract their pseudopodia, lose their
stress fibers, and adopt a less contractile phenotype (25, 27).
The comparison between the high stress (high cell density
and/or initial contraction) and low stress (low cell density
and/or density-independent contraction) conditions highlights
the importance of scleral matrix stress on themechanical prop-
erties of the endogenous cells. Several studies have quantified
the force exerted by cells on a collagen matrix before release.
For example, Kolodney and Wysolmerski (28) reported that
chick fibroblasts (7.7  105 cells/cm3) exert a force equivalent
of 4.5  104 dynes/cm2. Although the current study used a
higher collagen content than the Kolodney and Wysolmerski
study (2.1 mg/ml versus 0.9 mg/ml) (28), and thus the cells
experienced less stress in the current study, forces produced in
the highest density matrix would be comparable. Assuming a
normal intraocular pressure of 15 mm Hg and consistent
matrix properties for the eye, the in vivo scleral force would be
equivalent to 2  104 dynes/cm2. Thus, given that the forces
exerted in vivo and in vitro are likely similar, scleral fibroblasts
should exhibit a contractile phenotype in vivo.
In addition to mechanical tension being an important regu-
lator of cellular contraction, studies have also shown mechani-
cal tension to mediate changes in scleral cell gene/protein
expression (29–31). Although a recent gene array study (30)
has highlighted the large number of genes in the sclera that are
under the control of mechanical factors, other studies have
concentrated on stress-induced scleral ECM remodeling, spe-
cifically reporting decreased collagen synthesis and increased
matrix metalloproteinase-2 activity (29, 31). Thus, it is likely
that the intrinsic contractile capacity of scleral cells is impor-
tant in providing resistance to the expansile forces in the eye
generated by the intraocular pressure. Furthermore, the extent
of mechanical tension is likely to be critical in regulating
remodeling of the scleral matrix. It follows that all such mech-
anisms are likely to be important in determining overall eye size
and, therefore, refractive error.
Although the stress experienced by scleral cells is an impor-
tant regulator of cellular contraction, the growth factor TGF-
is also known to be a potent mediator of cellular mechanical
properties and fibroblast to myofibroblast differentiation (32,
33). The in vitro data of the current study showing that TGF-
can increase scleral cell-mediatedmatrix contraction by induc-
ingmyofibroblast differentiation (as indicated by up-regulation
of -SMA expression) support previous work in other tissue
systems. Individually, each of the TGF- isoforms can signifi-
cantly up-regulate -SMA expression in scleral cells (1500%
for TGF-1 and TGF-3), with TGF-3 the most potent of the
three isoforms. This is surprising given that our previous work
showed TGF-3 to be the least potent inducer of scleral colla-
gen production (16), and there is a high correlation between
myofibroblast differentiation (i.e. increased -SMA) and
increased collagen production (34, 35). TGF-3 is generally
found to be involved in the organized remodeling of ECM
rather than the relatively disorganized fibrotic process of myo-
fibroblast-mediated ECMproduction (36). Indeed our previous
work shows that despite the scleral cells expressing TGF-3,
both the normal and myopic eye sclerae have an organized col-
lagen matrix (7). We, therefore, speculate that TGF-3 plays a
different role in vivo to that found in vitro, a phenomenon also
reported in a previous study where TGF-3 acted as a positive
regulator ofmyofibroblast differentiation in vitrobutwas found
to negatively regulate differentiation in vivo (32).
Although in vitro data suggest that the myopia-related
decreases in TGF- isoforms are sufficient to reduce scleral
fibroblast to myofibroblast differentiation (reduced -SMA
expression) and cell contraction (see Fig. 7), the in vivo data
highlight a more complex regulatory pathway. A non-signifi-
cant increase in -SMA expression was observed during myo-
pia development, with the data demonstrating much more
inter-animal variability than has been our experience quantify-
ing many other scleral mRNAs in myopia. Furthermore, under
conditions in which the myopic eye was actually starting to
decrease in size (recovery from myopia), both -SMA expres-
sion and the variability of its expression were significantly
decreased. Evidence formultiple regulatory pathways, acting in
opposition or in concert with each other depending on the
direction of eye growth, comes from the capacity of two distinct
pathways, TGF- signaling or matrix stress, to regulate myofi-
broblast differentiation (14). Although decreased TGF- levels
would reduce -SMA expression and contraction during myo-
FIGURE 8. The effect of stress on TGF- induced regulation of -SMA
expression. Scleral fibroblasts were seeded into collagen type I matrices,
treated with different levels of TGF- (reflecting normal, 1 day myopia, 5 day
myopia conditions) and exposed to either no stress or a static stress (8.5%
elongation) for 5 days. The combined effect of TGF- and stress on -SMA
gene expression was assessed using real-time PCR. Gene expression data
were corrected for hypoxanthine phosphoribosyltransferase content, and all
datawere expressed relative to the-SMA levels found in the cells exposed to
TGF- levels found in normal eyes. n 3; *, p 0.05.
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pia development, these decreases also bring about concurrent
reductions in ECM production and scleral thickness, which
ultimately increase matrix stress (7, 16, 37, 38). These two
potentially competing effects were modeled in vitro using a
three-dimensional culture system in which both TGF- and
uniaxial stress levels could be accurately imposed. In those gels
exposed to physiological levels of stress, large, but variable ele-
vations in -SMA expression were observed, similar to that
seen in vivo. Contrary to the opposing forces during myopia
development, in recovery both TGF- expression and matrix
stress are reduced. Evidence for reducedmatrix stress in recov-
ery comes from previous work demonstrating a rapid increase
in glycosaminoglycan levels after 24 h of recovery frommyopia
(8, 9, 16). Such increases in glycosaminoglycan content have
been shown to shield the matrix from the effects of mechanical
stress (39). Overall, the in vivo and in vitro data support the
hypothesis that during myopia development the two -SMA
regulatory pathways (TGF- and matrix stress) oppose each
other, resulting in a net increase in -SMA expression with
increased variation. During recovery, however, the two path-
ways are synchronized, resulting in the highly reproducible
down-regulation of -SMA expression.
In summary, the current study supports the presence of a
constant myofibroblast population in the sclera. These cells
exhibit a contractile phenotype that can be modulated by
TGF- isoforms and imposed stress. In vivo, the presence of
two pathways mediating -SMA expression act either in an
opposing (myopic conditions) or synchronized (recovery)man-
ner. Although TGF- is a major contributor to the remodeling
of the sclera during changes in eye growth, it is matrix stress
that is the major determinate of scleral cell phenotype.
REFERENCES
1. Curtin, B. J. (1985) TheMyopias: Basic Science and Clinical Management,
Harper and Row, Philadelphia
2. Norton, T. T., andMiller, E. J. (1995) Investig. Ophthalmol. Vis. Sci. 3517,
760 (Abstr. 3517)
3. Zorn, N., Hernandez, M. R., Norton, T. T., Yang, J., and Ye, H. O. (1992)
Investig. Ophthalmol. Vis. Sci. 1811, 1053 (Abstr. 1811)
4. Phillips, J. R., Khalaj, M., and McBrien, N. A. (2000) Investig. Ophthalmol.
Vis. Sci. 41, 2028–2034
5. Siegwart, J. T., and Norton, T. T. (1999) Vision Res. 39, 387–407
6. Avetisov, E. S., Savitskaya, N. F., Vinetskaya, M. I., and Iomdina, E. N.
(1984)Metab. Pediatr. Syst. Ophthalmol. 7, 183–188
7. McBrien,N.A., Cornell, L.M., andGentle, A. (2001) Investig. Ophthalmol.
Vis. Sci. 42, 2179–2187
8. McBrien, N. A., Lawlor, P., and Gentle, A. (2000) Investig. Ophthalmol.
Vis. Sci. 41, 3713–3719
9. Moring, A. G., Baker, J. R., and Norton, T. T. (2007) Investig. Ophthalmol.
Vis. Sci. 48, 2947–2956
10. Kasza, K. E., Rowat, A. C., Liu, J., Angelini, T. E., Brangwynne, C. P.,
Koenderink, G. H., and Weitz, D. A. (2007) Curr. Opin. Cell Biol. 19,
101–107
11. Phillips, J. R., andMcBrien, N. A. (2004) Investig. Ophthalmol. Vis. Sci. 45,
758–763
12. Hinz, B., Celetta, G., Tomasek, J. J., Gabbiani, G., and Chaponnier, C.
(2001)Mol. Biol. Cell 12, 2730–2741
13. Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., and Brown, R. A.
(2002) Nat. Rev. Mol. Cell Biol. 3, 349–363
14. Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M. L.,
and Gabbiani, G. (2007) Am. J. Pathol. 170, 1807–1816
15. Poukens, V., Glasgow, B. J., and Demer, J. L. (1998) Investig. Ophthalmol.
Vis. Sci. 39, 1765–1774
16. Jobling, A. I., Nguyen, M., Gentle, A., and McBrien, N. A. (2004) J. Biol.
Chem. 279, 18121–18126
17. McBrien, N. A., and Norton, T. T. (1992) Vision Res. 32, 843–852
18. McBrien, N. A., and Gentle, A. (2003) Prog. Retin. Eye Res. 22, 307–338
19. Siegwart, J. T., and Norton, T. T. (1994) Lab. Anim. Sci. 44, 213–215
20. Gentle, A., and McBrien, N. A. (1999) Exp. Eye Res. 68, 155–163
21. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156–159
22. Towbin, H., and Gordon, J. (1984) J. Immunol. Methods 72, 313–340
23. Ehrlich, H. P., and Rittenberg, T. (2000) J. Cell. Physiol. 185, 432–439
24. Redden, R. A., and Doolin, E. J. (2006) In Vitro Cell Dev. Biol. Anim. 42,
70–74
25. Mochitate, K., Pawelek, P., and Grinnell, F. (1991) Exp. Cell Res. 193,
198–207
26. He, Y., and Grinnell, F. (1994) J. Cell Biol. 126, 457–464
27. Tomasek, J. J., Haaksma, C. J., Eddy, R. J., and Vaughan,M. B. (1992)Anat.
Rec. 232, 359–368
28. Kolodney, M. S., and Wysolmerski, R. B. (1992) J. Cell Biol. 117, 73–82
29. Fujikura, H., Seko, Y., Tokoro, T., Mochizuki, M., and Shimokawa, H.
(2002) Jpn. J. Ophthalmol. 46, 24–30
30. Cui, W., Bryant, M. R., Sweet, P. M., and McDonnell, P. J. (2004) Exp. Eye
Res. 78, 275–284
31. Shelton, L., and Rada, J. S. (2007) Exp. Eye Res. 84, 314–322
32. Serini, G., and Gabbiani, G. (1999) Exp. Cell Res. 250, 273–283
33. Cordeiro, M. F., Bhattacharya, S. S., Schultz, G. S., and Khaw, P. T. (2000)
Investig. Ophthalmol. Vis. Sci. 41, 756–763
34. Petrov, V. V., Fagard, R. H., and Lijnen, P. J. (2002) Hypertension 39,
258–263
35. MacKenna, D., Summerour, S. R., and Villarreal, F. J. (2000) Cardiovasc.
Res. 46, 257–263
36. Shah, M., Foreman, D. M., and Ferguson, M. W. (1995) J. Cell Sci. 108,
985–1002
37. Gentle, A., Liu, Y., Martin, J. E., Conti, G. L., and McBrien, N. A. (2003)
J. Biol. Chem. 278, 16587–16594
38. Bellezza, A. J., Hart, R. T., and Burgoyne, C. F. (2000) Investig. Ophthalmol.
Vis. Sci. 41, 2991–3000
39. Schmidt, M. B., Mow, V. C., Chun, L. E., and Eyre, D. R. (1990) J. Orthop.
Res. 8, 353–363
Scleral Cell Phenotype Regulation andMyopic Eye Growth
JANUARY 23, 2009•VOLUME 284•NUMBER 4 JOURNAL OF BIOLOGICAL CHEMISTRY 2079
 at D
eakin U
niversity (CAUL) on M
ay 25, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
